MRRS adds "Global Viral Infections Market to 2021 – Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics" latest studies, published in November 2016. It is a professional and in-depth study.

Summary
Viruses are infectious particles comprising a nucleic acid core – consisting of either DNA or RNA – and a protein coat known as a capsid. Infections attributable to viral pathogens are transmitted, directly or indirectly, from one person to another or from animal to human. Viruses replicate by exploiting the resources of their host cells, usually to the detriment of the host. As viral pathogens are exceptionally diverse, the morbidity associated with viral infections varies significantly depending on the virus in question. This report covers all viral infections, although particular focus is given to four key indications within this disease cluster: Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and influenza. The global viral infections market was valued at $74.0 billion in 2014, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 6.8%, reaching $117.6 billion in 2021. Key drivers of this growth will be the expanding treatment population and uptake of recently approved highly priced antiviral agents, as well as promising late-stage candidates that are expected to be priced highly.

Table of Contents
3 Marketed Products 22
3.1 Multiple Indications 22
3.1.1 Viread - Gilead 22
3.1.2 Epivir/Epivir-HBV - ViiV Healthcare 23
3.1.3 Pegasys - F. Hoffmann La Roche 25
3.2 Human Immunodeficiency Virus (HIV) 26
3.2.1 Truvada - Gilead 26
3.2.2 Atripla - Gilead 28
3.2.3 Stribild - Gilead 29
3.2.4 Tivicay - ViiV Healthcare 31
3.2.5 Triumeq - ViiV Healthcare 32
3.2.6 Genvoya - Gilead 33
3.3 Hepatitis C Virus (HCV) 35
3.3.1 Olysio - Janssen 35
3.3.2 Sovaldi and Harvoni - Gilead 36
3.3.3 Zepatier - Merck and Co. 38
3.4 Hepatitis B Virus 39
3.4.1 Baraclude - Bristol-Myers Squibb 39
3.5 Influenza Virus 40
3.5.1 Tamiflu - Roche 40
4 Pipeline 42
4.1 Overview 42
4.2 Pipeline Products by Stage of Development and Molecule Type 42
4.3 Pipeline Products by Molecular Target 47
4.4 Clinical Trials Landscape 50
4.4.1 Clinical Trial Failure Rates 51
4.4.2 Clinical Trial Duration 54
4.4.3 Clinical Trial Size 57
4.4.4 Cumulative Clinical Trial Size 61
4.4.5 Conclusion 63
4.5 Assessment of Key Pipeline Products 63
4.5.1 Sofosbuvir in Combination with Velpatasvir - Gilead 63
4.5.2 Tenofovir alafenamide fumarate - Gilead 65
4.5.3 Descovy - Gilead 66
4.5.4 Cobicistat, darunavir, emtricitabine and TAF - Johnson & Johnson 67
4.5.5 Beclabuvir hydrochloride - Bristol-Myers Squibb 68
4.5.6 V-212 - Merck 69
5 Multi-scenario Market Forecast to 2021 71......

List of Tables and Figures 
Table 1: Common Routes of Viral Entry 18
Table 2: Viral Infections Therapeutics Market, Global, Licensing Deals Valued Above $100m, 2006-2016 95
Table 3: Viral Infections Therapeutics Market, Global, Co-development Deals Valued Above $100m, 2006-2016 103
Table 4: Table of All Pipeline Products 113
Figure 1: Viral Infections Therapeutics Market, Major Markets, HIV Prevalence (‘000), 2014-2021 12
Figure 2: Viral Infections Therapeutics Market, Major Markets, HCV Prevalence (‘000), 2014-2021 14
Figure 3: Viral Infections Therapeutics Market, Global, Historic and Forecast Annual Revenues for Viread ($m), 2006-2021 23
Figure 4: Viral Infections Therapeutics Market, Global, Historic and Forecast Annual Revenues for Epivir/Epivir-HBV ($m), 2006-2021 24
Figure 5: Viral Infections Therapeutics Market, Global, Historic and Forecast Annual Revenues for Pegasys ($m), 2006-2021 26
Figure 6: Viral Infections Therapeutics Market, Global, Historic and Forecast Annual Revenues for Truvada ($bn), 2006-2021 28.....

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/global-viral-infections-market-to-2021-promising-new-competitors-and-expanding-treatment-population-to-offset-increased-uptake-of-generics

About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.

Ask a sample and any further questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/